Univest Financial Corp Abb Vie Inc. Transaction History

Univest Financial Corp

$1.51 Billion
Q3 2024

A detailed history of Univest Financial Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Univest Financial Corp holds 8,227 shares of ABBV stock, worth $1.48 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

8,227

Holding current value

$1.48 Million

% of portfolio

0.11%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $1.35 Million - $1.64 Million	8,227 New	8,227 $1.62 Million
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $4,916 - $5,662	-34 Reduced 1.93%	1,728 $275,000
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $102,487 - $122,909	-741 Reduced 29.6%	1,762 $284,000
Q3 2022 Nov 03, 2022	SELL	$134.21 - $153.93 $120,520 - $138,229	-898 Reduced 26.4%	2,503 $336,000
Q2 2022 Aug 05, 2022	SELL	$137.62 - $174.96 $88,076 - $111,974	-640 Reduced 15.84%	3,401 $521,000
Q1 2022 May 05, 2022	SELL	$131.98 - $163.75 $4.86 Million - $6.03 Million	-36,847 Reduced 90.12%	4,041 $655,000
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $44,798 - $56,682	-417 Reduced 1.01%	40,888 $5.54 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $70,436 - $79,956	662 Added 1.63%	41,305 $4.46 Million
Q2 2021 Jul 20, 2021	SELL	$105.21 - $117.21 $143,611 - $159,991	-1,365 Reduced 3.25%	40,643 $4.58 Million
Q1 2021 Apr 14, 2021	BUY	$102.3 - $112.62 $11,969 - $13,176	117 Added 0.28%	42,008 $4.55 Million
Q4 2020 Jan 19, 2021	BUY	$80.49 - $108.67 $28,895 - $39,012	359 Added 0.86%	41,891 $4.49 Million
Q3 2020 Oct 13, 2020	SELL	$85.91 - $100.83 $71,992 - $84,495	-838 Reduced 1.98%	41,532 $3.64 Million
Q2 2020 Jul 09, 2020	SELL	$73.37 - $98.18 $30,521 - $40,842	-416 Reduced 0.97%	42,370 $4.16 Million
Q1 2020 May 05, 2020	SELL	$64.5 - $97.79 $1.46 Million - $2.22 Million	-22,700 Reduced 34.66%	42,786 $3.26 Million
Q4 2019 Jan 14, 2020	BUY	$72.13 - $90.25 $1.32 Million - $1.65 Million	18,268 Added 38.69%	65,486 $4.1 Million
Q3 2019 Nov 06, 2019	BUY	$62.98 - $75.72 $27,018 - $32,483	429 Added 0.92%	47,218 $3.58 Million
Q2 2019 Jul 12, 2019	BUY	$65.7 - $83.98 $70,758 - $90,446	1,077 Added 2.36%	46,789 $3.4 Million
Q1 2019 Apr 09, 2019	BUY	$77.14 - $90.79 $239,905 - $282,356	3,110 Added 7.3%	45,712 $3.68 Million
Q4 2018 Jan 28, 2019	BUY	$77.85 - $96.01 $169,946 - $209,589	2,183 Added 5.4%	42,602 $3.93 Million
Q3 2018 Oct 10, 2018	BUY	$88.91 - $98.84 $35,652 - $39,634	401 Added 1.0%	40,419 $3.82 Million
Q2 2018 Jul 17, 2018	BUY	$89.78 - $106.23 $25,317 - $29,956	282 Added 0.71%	40,018 $3.71 Million
Q1 2018 Apr 19, 2018	SELL	$92.01 - $123.21 $872,254 - $1.17 Million	-9,480 Reduced 19.26%	39,736 $3.76 Million
Q4 2017 Jan 22, 2018	SELL	$89.56 - $98.21 $263,664 - $289,130	-2,944 Reduced 5.64%	49,216 $4.76 Million
Q3 2017 Oct 13, 2017	BUY	$69.85 - $89.22 $3.64 Million - $4.65 Million	52,160	52,160 $4.64 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Univest Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Univest Financial Corp with notifications on news.

Account

Univest Financial Corp Abb Vie Inc. Transaction History